Patni Rajiv has filed 5 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 17000 shares of BioXcel Therapeutics, Inc. ($BTAI) on January 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 9, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Patni Rajiv | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 14,196,000 | 9999.99% | 0.12% |
| June 4, 2025 | Quince Therapeutics, Inc. | $QNCX | Patni Rajiv | Not found | A | Director Stock Option (Right to Buy) | 27000 | $0.00 | 27,000.0000 | 44,001,643 | 9999.99% | 0.06% |
| Jan. 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Patni Rajiv | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 2,535,000 | 9999.99% | 1.74% |
| June 5, 2024 | Quince Therapeutics, Inc. | $QNCX | Patni Rajiv | Not found | A | Employee Stock Option (right to buy) | 13500 | $0.00 | 13,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2024 | Quince Therapeutics, Inc. | $QNCX | Patni Rajiv | Not found | A | Employee Stock Option (right to buy) | 54000 | $0.00 | 54,000.0000 | 0 | 9999.99% | 0.00% |